Skip to content

Understanding How Different Foods Affect Blood Sugar Levels in Healthy People

A study to evaluate effect of consumption of food products on Glycemic index in healthy human volunteers - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062735
Enrollment
14
Registered
2024-02-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Product 6: ATS- 36: The the product equivalent to 25 g of carbohydrate to be mixed with 66 ± 10 ml water Intervention2: Product 5: MMD-39: The product equivalent to 25 g of carbohydrate

Sponsors

Amway Global Services India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy adults in the age group of 18 and 45 years – male and female -1:1 ratio Fasting blood glucose levels more than 100mg perdL. BMI should be between 18.5 to 23 kg per m2 Lipid profile (Total cholesterol) within normal range as applicable Agree to participate in the study. Able and willing to follow all study related instructions. Must be willing to give written informed consent and comply with the study procedures. Subject’s complete blood count parameters to be within clinically acceptable range by Investigator.

Exclusion criteria

Exclusion criteria: Subjects with BMI less than 18.5kg per m2 or more than 23 kg per m2 will be excluded from the study. Total cholesterol higher than normal range. Subjects particularly on any special diet Subjects suffering from any systemic disorders (diabetes, cardiovascular, renal, pulmonary, endocrine, or neurological disorders, ulcers, dermatologic disorders, autoimmune diseases) or severe food allergies; an active infectious disease (HBV, HCV, HIV) urrent diagnosis or a history of relevant depressive episodes or of panic attacks, psychosis, bipolar or eating disorders Pregnant or lactating women Patient having participated in any other clinical trial within one month prior to screening

Design outcomes

Primary

MeasureTime frame
To assess glycemic index using blood sugar levels measured at fixed intervals (-5 15 30 45 60 90 and 120 min) in a day with respect to reference productTimepoint: -5 15 30 45 60 90 and 120 min

Secondary

MeasureTime frame
- To assess change in hematological and biochemical parameters from baseline to end of the study. - Assessment adverse events during the study period.Timepoint: At baseline & end of the Study

Countries

India

Contacts

Public ContactDr Sudha Raj

Amway Global Services India Pvt Ltd

Palaniyamma.Durairaj@Amway.com7022247227

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026